Adults with obesity who dread weekly injections now have a new option: a daily pill. The FDA approved Foundayo, the brand ...

Orlistat and Zepbound are two U.S. Food and Drug Administration (FDA)-approved weight loss medications that work in different ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains ...

The U.S. Food and Drug Administration has added a warning about kidney injury to the labeling of a popular over-the-counter weight-loss pill. According to drug-safety reporting , ...

Eli Lilly's U.S. patent for tirzepatide, ​the active ingredient in its Mounjaro for patients with Type II diabetes ​and ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA on Thursday said it would exclude the active ingredients in popular GLP-1 weight loss drugs from its 503B list, which ...

Eli Lilly’s next-generation, investigational weight-loss drug is just a few clicks away from being delivered to your door.

The US Food and Drug Administration (FDA) has published draft guidance for sponsors developing drugs and biologics for weight reduction for patients who are obese. The guidance focuses on using body ...

The U.S. Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long ...

It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.